• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Executive Chairman Auld David V converted options into 7,899 shares, was granted 9,044 shares and covered exercise/tax liability with 2,923 shares, increasing direct ownership by 2% to 890,672 units (SEC Form 4)

    4/22/25 4:00:30 PM ET
    $DHI
    Homebuilding
    Consumer Discretionary
    Get the next $DHI alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Auld David V

    (Last) (First) (Middle)
    1341 HORTON CIRCLE

    (Street)
    ARLINGTON TX 76011

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    HORTON D R INC /DE/ [ DHI ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    X Officer (give title below) Other (specify below)
    Executive Chairman
    3. Date of Earliest Transaction (Month/Day/Year)
    04/21/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 04/21/2025 M 7,899 A (1) 884,551 D
    Common Stock 04/21/2025 A 9,044(2) A $0 893,595 D
    Common Stock 04/21/2025 F 2,923(3) D $120.36 890,672(4) D
    Common Stock 211,200(4) I Held by Trusts of Mr. Auld's children.
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Restricted Stock Unit (1) 04/21/2025 M 7,899 (5) (5) Common Stock 7,899 $0 7,016 D
    Explanation of Responses:
    1. Each restricted stock unit converts into one share of DHI common stock.
    2. These shares were issued pursuant to Mr. Auld's bonus earned for the six-months ended March 31, 2025.
    3. These shares were surrendered to issuer to cover tax obligations of the 7,899 shares of DHI common stock issued upon the vesting of the restricted stock units awarded April 20, 2023.
    4. Following all transactions listed on this Form 4, Mr. Auld owns directly 890,672 shares of DHI common stock and indirectly holds 211,200 shares of DHI common stock.
    5. On April 20, 2023, the reporting person was granted 23,698 restricted stock units, vesting in three annual installments beginning April 20, 2024.
    /s/ David V. Auld 04/22/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $DHI alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $DHI

    DatePrice TargetRatingAnalyst
    3/6/2025$164.00Neutral → Buy
    Seaport Research Partners
    1/27/2025$160.00 → $150.00Buy → Neutral
    BofA Securities
    12/13/2024$188.00 → $156.00Neutral → Underweight
    Analyst
    12/11/2024$192.00 → $170.00Overweight → Equal Weight
    Barclays
    12/10/2024$200.00 → $183.00Outperform → Mkt Perform
    Keefe Bruyette
    11/7/2024Outperform → Mkt Perform
    Raymond James
    10/15/2024$165.00Underperform → Neutral
    Wedbush
    7/2/2024$181.00 → $156.00Buy → Neutral
    Citigroup
    More analyst ratings